Conversion surgery for unresectable pancreatic cancer with liver metastasis can significantly improve survival for select patients.
- In a study of 90 patients, overall survival after conversion surgery was 39.7 months, with earlier treatment yielding 53.1 months from initial diagnosis.
- Preoperative normalization of CA 19-9 and negative lymph node metastasis were key factors linked to better outcomes.
Selecting patients who respond positively to chemotherapy for conversion surgery may enhance treatment success.
Journal Article by Hashimoto D, Ikeura T (…) Takeyama Y et 41 al. in J Gastroenterol
© 2026. The Author(s), under exclusive licence to Japanese Society of Gastroenterology.